Bisphosphonate-and disumab-related gingival disorders: case analysis from the US Food and Drug Administration Adverse Event Reporting System
L Wang, W Zhang, C Zhao, Z Fu - Frontiers in Endocrinology, 2024 - frontiersin.org
Prior research has indicated that bisphosphonates (BPs) can improve periodontal disease
because of their anti-osteoporosis properties. In vitro studies have shown that BPs induce …
because of their anti-osteoporosis properties. In vitro studies have shown that BPs induce …
Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo
GF Draenert, DO Huetzen, PW Kämmerer… - Journal of Cranio …, 2012 - Elsevier
INTRODUCTION: Bisphosphonates are important and effective drugs in oncology and
osteoporosis therapy. They accumulate in the bone matrix becoming released and active by …
osteoporosis therapy. They accumulate in the bone matrix becoming released and active by …
[HTML][HTML] Osteonecrosis of the jaws in patients treated with bisphosphonates
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis
of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the …
of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the …
Oral care compositions comprising geranylgeraniol and methods of use thereof
B Tan, A Trias, JP Lizotte - US Patent App. 18/473,740, 2024 - Google Patents
BACKGROUND [0003] The oral cavityisestimated to contain over700 microbialspecies.
withonestudyestimatingthepresence of over19. 000phylotypes. One …
withonestudyestimatingthepresence of over19. 000phylotypes. One …
Anti-resorptive treatment in osteoporosis and their deleterious effects on maxillary bone metabolism in clinical dentistry
D Soto-Peñazola, M Peñarrocha-Diago… - Bone Response to …, 2017 - Elsevier
Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely
prescribed for the treatment of osteoporosis and are also used in patients with multiple …
prescribed for the treatment of osteoporosis and are also used in patients with multiple …
[引用][C] Comments on Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts by Cozin M et al (2011)
T Ziebart, C Walter - Journal of Oral and Maxillofacial Surgery, 2012 - joms.org
To the Editor:—We read the interesting article “Novel Therapy to Reverse the Cellular Effects
of Bisphosphonates on Primary Human Oral Fibroblasts” by Cozin et al. We would like to …
of Bisphosphonates on Primary Human Oral Fibroblasts” by Cozin et al. We would like to …